Article Details
Retrieved on: 2021-05-12 09:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The RECOVERY trial announced in February that the monoclonal antibody tocilizumab cut the risk of death in people hospitalized with severe COVID-19 ...
Article found on: www.nature.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here